In addition to autonomous BCR signaling, external activation of the BCR through the CLL microenvironment has been suggested, with stroma cell expression of antigens such as vimentin and calreticulin which activate the BCR (47). The gene discussed is CALR; the disease is B-cell chronic lymphocytic leukemia.